Can Genetic Testing Change Your Clinical Trial Eligibility?
Articles Blog

Can Genetic Testing Change Your Clinical Trial Eligibility?


Jana Pruski-Clark: Although many people utilize
the results of genetic testing to make decisions about their surgical options at the time of
a breast cancer diagnosis, I am often asked questions about the relationship of genetic
testing results with treatment options including chemotherapy and radiation. Although the results of genetic testing primarily
relate to surgical decision making options at the time of diagnosis, we do know that
it can relate to the availability of research options for treatment as well. For example,
there has been a lot of research and news in the last few years about PARP inhibitors
which appear to be more effective in the treatment of cancers in individuals who carry BRCA1
or BRCA2 mutations. If you are thinking about your research options
for chemotherapy treatment, I would encourage you to ask your doctor about whether or not
the results of BRCA1 and BRCA2 testing may be indicated for you. Another great option
is to utilize an organization called FORCE which stands for Facing Our Risk of Cancer
Empowered. Their website is www.facingourrisk.org and
they have a wonderful list of research studies related to PARP inhibitors and also related
to other components of BRCA1 and BRCA2 test results, so you talk to your doctor’s office
about any local research option that are available within the facility you are receiving treatment,
but also going to the FORCE website and looking at the options available listed their to determinate
if their may perhaps the even national research options that my be appropriate for you depending
on your stage of diagnosis, the treatment that you have already received, and potentially
your genetic testing results.

One thought on “Can Genetic Testing Change Your Clinical Trial Eligibility?

  1. Can Genetic Testing Change Your Clinical Trial Eligibility?

    Many people utilize genetic testing to understand more about their breast cancer. Countless patients with a family history of breast cancer have found out that they have hereditary cancer and carry the genetic mutation BRCA1 & BRCA2. 

    But does carrying a BRCA1 & BRCA2 gene change the clinical trials you are eligible for? Well, it might. InformedDNA’s Jana Pruski-Clark says, “I would encourage you to ask your doctor about whether or not the results of BRCA1 and BRCA2 testing may be indicated for you.”

    Find out from Jana Pruski-Clark how genetic testing can change your clinical trial eligibility.

    #BreastCancer #GeneticTesting #ClinicalTrial

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top